Omeros Corporation

(NASDAQ:OMER)

Latest On Omeros Corporation (OMER):

Date/Time Type Description Signal Details
2023-05-17 06:30 ESTNewsOmeros: Q1 Earning Overview, Best Contrarian Biotech Play Of 2023N/A
2023-05-10 05:46 ESTNewsOmeros Corporation (OMER) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 16:40 ESTNewsOmeros GAAP EPS of -$0.63 misses by $0.09N/A
2023-05-09 02:50 ESTNewsOmeros Q1 2023 Earnings PreviewN/A
2023-04-25 20:18 ESTNewsOmeros reports positive data for rare blood disorder candidateN/A
2023-04-11 01:47 ESTNewsOmeros awarded $6.69M grant from NIH for cocaine use disorder treatmentN/A
2023-03-27 18:48 ESTNewsOmeros Q4: Strong Financials And IgAN Pipeline Readout In Q3 23N/A
2023-03-15 00:03 ESTNewsOmeros stock climbs amid Q4 Omidria royalty revenue; eyes FDA refiling for narsoplimabN/A
2023-03-14 08:12 ESTNewsOmeros Corporation (OMER) Q4 2022 Earnings Call TranscriptN/A
2023-03-13 17:09 ESTNewsOmeros GAAP EPS of -$0.73 misses by $0.16N/A
2023-03-13 02:04 ESTNewsOmeros Q4 2022 Earnings PreviewN/A
2023-02-08 10:56 ESTNewsOmeros: $200M Added To The Company's Balance Sheet, Upgrading To Strong BuyN/A
2023-02-06 20:54 ESTNewsOmeros up 35% in premarket trading following $200M milestone paymentN/A
2023-02-04 12:40 ESTNewsOmeros: Worst Has Been Priced In, We Like Its IgAN Pipeline, Initiating With A BuyN/A
2022-12-27 10:19 ESTNewsOmeros' Deafening SilenceN/A
2022-11-10 03:58 ESTNewsOmeros GAAP EPS of -$0.28 beats by $0.28N/A
2022-11-10 03:58 ESTNewsOmeros Corporation (OMER) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 10:03 ESTNewsOmeros Q3 2022 Earnings PreviewN/A
2022-11-08 16:56 ESTNewsOmeros appeal of FDA Complete Response Letter on narsoplimab denied; shares down 7%N/A
2022-11-08 16:55 ESTNewsOmeros downgraded at Bank of America after FDA snub for narsoplimab appealN/A
2022-11-01 13:32 ESTNewsOmeros: FDA Appeal On Narsoplimab And Several 2023 Catalysts On DeckN/A
2022-10-05 09:58 ESTNewsOmeros: Taking It To The MaxN/A
2022-09-15 20:07 ESTNewsOmeros falls 11% after reporting clinical data for COVID-19 therapyN/A
2022-08-20 05:51 ESTNewsOmeros: Off To Never-Never LandN/A
2022-08-17 22:29 ESTNewsOmeros receives response from FDA on formal dispute resolution requestN/A
2022-08-16 11:56 ESTNewsOmeros: Managing An Investment After A Winning TradeN/A
2022-08-10 03:57 ESTNewsOmeros GAAP EPS of -$0.49N/A
2022-08-10 03:57 ESTNewsOmeros Corporation (OMER) CEO Gregory Demopulos on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 06:07 ESTNewsOmeros Q2 2022 Earnings PreviewN/A
2022-07-29 02:53 ESTNewsOmeros granted FDA’s orphan drug designation for PNH candidateN/A
2022-07-05 17:38 ESTNewsAfter gaining 69% in single trading day, Omeros stock gives back some gainsN/A
2022-07-04 07:08 ESTNewsOmeros: Follow The Bouncing BallN/A
2022-06-08 22:55 ESTNewsOmeros slips to 52-week low as stock down 9%N/A
2022-06-07 00:28 ESTNewsClover Health, Aurinia Pharma among the top 10 health care additions to Russell 3000 Index, Asensus Surgical, Clovis Oncology among top deletionsN/A
2022-06-02 12:43 ESTNewsOmeros: On Death's DoorN/A
2022-05-12 03:01 ESTNewsOmeros stock rises 7% after beating Q1 earnings estimateN/A
2022-05-11 07:21 ESTNewsOmeros GAAP EPS of -$0.53 beats by $0.08N/A
2022-05-11 07:21 ESTNewsOmeros Corporation (OMER) CEO Greg Demopulos on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 11:19 ESTNewsOmeros Q1 2022 Earnings PreviewN/A
2022-05-03 00:21 ESTNewsOmeros: The Weight Of The Wait, A ConundrumN/A
2022-03-02 04:45 ESTNewsOmeros Non-GAAP EPS of -$0.37 misses by $0.31N/A
2022-03-02 04:44 ESTNewsOmeros Corporation's (OMER) CEO Greg Demopulos On Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 10:49 ESTNewsOmeros Q4 2021 Earnings PreviewN/A
2022-02-21 13:04 ESTNewsOmeros: Despite Its Promise, The CRL Is A Huge ObstacleN/A
2022-01-20 07:52 ESTNewsOmeros responds to Complete Response Letter on narsoplimab for kidney damageN/A
2022-01-19 00:54 ESTNewsOmeros could trade as a pure-play biotech after divesting Omidria - CantorN/A
2021-12-06 20:03 ESTNewsOmeros: A New Year BeckonsN/A
2021-12-02 22:53 ESTNewsOmeros to sell OMIDRIA franchise to Rayner Surgical for more than $1BN/A
2021-11-10 13:19 ESTNewsOmeros EPS beats by $0.01, beats on revenueN/A
2021-11-10 13:19 ESTNewsOmeros Corporation (OMER) CEO Greg Demopulos on Q3 2021 Results - Earnings Call TranscriptN/A

About Omeros Corporation (OMER):

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system (CNS), and immune-related diseases. It provides OMIDRIA for use in cataract surgery or intraocular lens replacement in the United States. The company's clinical programs include Narsoplimab (OMS721/MASP-2) for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN), atypical hemolytic uremic syndrome (aHUS), and COVID-19; and Phase II clinical trial to treat lupus nephritis and other renal diseases. Its clinical programs also consist of PPAR? (OMS405) to treat opioid and nicotine addiction; PDE7 (OMS527) for treating addiction and compulsive disorders, and movement disorders; and MASP-3 (OMS906) for paroxysmal nocturnal hemoglobinuria (PNH) and other alternative pathway disorders. The company's preclinical programs comprise MASP-2-small-molecule inhibitors used for the treatment of aHUS, IgAN, HSCT-TMA, and age-related macular degeneration; longer-acting second generation antibody targeting MASP-2; and MASP-3-small-molecule inhibitors to treat PNH and other alternative pathway disorders. Its preclinical programs include G protein-coupled receptor (GPCR) platform, including GPR174, GPR151, GPR161, and other Class A orphan GPCRs for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington.

See Advanced Chart

General

  • Name Omeros Corporation
  • Symbol OMER
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 277
  • Last Split Factor1:1
  • Last Split Date2009-10-02
  • Fiscal Year EndDecember
  • IPO Date2009-10-08
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.omeros.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 15.4
  • Enterprise Value Revenue 18.49
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.77
  • Next Year EPS Estimate -$1.12
  • Next Quarter EPS Estimate -$0.54
  • Profit Margin -187%
  • Operating Margin -150%
  • Return on Assets -43%
  • Revenue 73.81 million
  • Earnings Per Share -$2.08
  • Revenue Per Share $1.29
  • Gross Profit 6.17 million
  • Quarterly Earnings Growth -68.2%
View More

Highlights

  • Market Capitalization 1.23 billion
  • EBITDA -81135000
  • PE Ratio -1.97
  • PEG Ratio -0.17
  • Analyst Target Price $27.33
  • Book Value Per Share -$2.65
View More

Share Statistics

  • Shares Outstanding 61.93 million
  • Shares Float 55.03 million
  • % Held by Insiders 441%
  • % Held by Institutions 57.36%
  • Shares Short 12.55 million
  • Shares Short Prior Month 12.76 million
  • Short Ratio 16
  • Short % of Float 21%
  • Short % of Shares Outstanding 20%
View More

Technicals

  • Beta 1.42
  • 52 Week High $23.14
  • 52 Week Low $9.25
  • 50 Day Moving Average 20.56
  • 200 Day Moving Average 14.72
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Omeros Corporation (OMER) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Omeros Corporation (OMER) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.60-$0.6710.39%
2020-09-302020-11-09$N/A-$0.34-$0.4930.04%
2020-06-302020-08-10$N/A-$0.61-$0.59-4.1%
2020-03-312020-05-11$23.54 million-$0.53-$0.34-55.88%
2019-12-312020-03-02$33.42 million-$0.58-$0.40-45%
2019-09-302019-11-12$29.86 million-$0.33-$0.4119.02%
2019-06-302019-08-08$26.75 million-$0.29-$0.4434.09%
2019-03-312019-05-09$21.78 million-$0.50-$0.47-5.82%
2018-12-312019-03-01$22.02 million-$0.48-$0.7333.89%
2018-09-302018-11-08$4.61 million-$0.81-$0.71-14.62%
2018-06-302018-08-09$1.66 million-$0.70-$0.62-12.45%
2018-03-312018-05-10$1.59 million-$0.62-$0.59-5.68%
2017-12-312018-03-01$13.76 million-$0.34-$0.18-91.55%
2017-09-302017-11-09$21.66 million-$0.16-$0.3453.22%
2017-06-302017-08-08$17.15 million-$0.33-$0.3710.81%
2017-03-312017-05-10$12.26 million-$0.34-$0.364.23%
2016-12-312017-03-16$12.91 million-$0.33-$0.5641.96%
2016-09-302016-11-09$11.29 million-$0.34-$0.364.9%
2016-06-302016-08-09$10 million-$0.32-$0.4934.16%
2016-03-312016-05-10$7.42 million-$0.54-$0.43-25.58%
2015-12-312016-03-07$6.68 million-$0.49-$0.5917.87%
2015-09-302015-11-09$3.26 million-$0.53-$0.47-12.77%
2015-06-302015-08-10$3.19 million-$0.44-$0.5621.43%
2015-03-312015-05-11$388000-$0.51-$0.6319.05%
2014-12-312015-03-16$180000-$0.61-$0.621.61%
2014-09-302014-11-10$214000-$0.54-$0.598.47%
2014-06-302014-08-11$45000-$0.53-$0.565.36%
2014-03-312014-05-12$100000-$0.54-$0.45-20%
2013-12-312014-03-13$169000-$0.47-$0.38-23.68%
2013-09-302013-11-07$196000-$0.46-$0.44-4.55%
2013-06-302013-08-09$140000-$0.48-$0.38-26.32%
2013-03-312013-05-10$1.1 million-$0.40-$0.39-2.56%
2012-12-312013-03-18$1.58 million-$0.45-$0.34-32.35%
2012-09-302012-11-09$1.42 million-$0.36-$0.34-5.88%
2012-06-302012-08-07$1.53 million-$0.38-$0.36-5.56%
2012-03-312012-05-10$1.5 million-$0.35-$0.362.78%
2011-12-312012-03-15$1.14 million-$0.46-$0.35-31.43%
2011-09-302011-11-08$987000-$0.29-$0.3823.68%
2011-06-302011-08-09$1.16 million-$0.24-$0.3836.84%
2011-03-312011-05-10$1.24 million-$0.30-$0.3923.08%
2010-12-312011-03-15$976000-$0.32-$0.4934.69%
2010-09-302010-11-04$254000-$0.35-$0.3910.26%
2010-06-302010-08-10$497000-$0.36-$0.33-9.09%
2010-03-312010-05-12$378000-$0.31-$0.30-3.33%
2009-12-312010-03-31$434000-$0.28-$0.27-3.7%
2009-09-302009-11-19$442000-$0.33-$0.3710.81%

Omeros Corporation (OMER) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Omeros Corporation (OMER) Chart:

Omeros Corporation (OMER) News:

Below you will find a list of latest news for Omeros Corporation (OMER) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Omeros Corporation (OMER) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-1610CALL0 0881.21TRUE00
2025-05-1620CALL0 0491.35TRUE00
2025-05-1635.78CALL0 430280.51TRUE00
2025-05-1642.2CALL0 604178.6TRUE00
2025-05-1652.5CALL0 77193.35TRUE00
2025-05-1661.76CALL0 120273.16TRUE00
2025-05-1670.7CALL0 27552.85TRUE00
2025-05-1680.45CALL1 116899.29FALSE00
2025-05-1690.2CALL0 45196.2FALSE00
2025-05-16100.2CALL0 194499.77FALSE00
2025-05-16110.1CALL0 826192.92FALSE00
2025-05-16120.05CALL0 722196.19FALSE00
2025-05-16130.1CALL0 458193.58FALSE00
2025-05-16140.1CALL0 163209.26FALSE00
2025-05-16150.05CALL0 1504223.44FALSE00
2025-05-16160.42CALL0 411236.37FALSE00
2025-05-16170.09CALL0 89248.25FALSE00
2025-05-16180.14CALL0 65282.78FALSE00
2025-05-16190.35CALL0 7293.37FALSE00
2025-05-16200.05CALL0 633297.52FALSE00
2025-05-16250.05CALL0 27216.78FALSE00
2025-05-1610PUT0 0729.28FALSE00
2025-05-1620.3PUT0 2500465.04FALSE00
2025-05-1630.15PUT0 9331.71FALSE00
2025-05-1640PUT0 0205.33FALSE00
2025-05-1650.19PUT0 113178FALSE00
2025-05-1660.45PUT0 164101.86FALSE00
2025-05-1670.7PUT1 107121.8FALSE-0.05-0.07
2025-05-1681.45PUT1 546109.12TRUE1.450
2025-05-1692.8PUT0 520117.04TRUE00
2025-05-16103.05PUT0 564146.03TRUE00
2025-05-16113.83PUT0 118170.25TRUE00
2025-05-16123.8PUT0 77158.09TRUE00
2025-05-16134.3PUT0 1187.73TRUE00
2025-05-16145.8PUT0 0190.51TRUE00
2025-05-16150PUT0 0280TRUE00
2025-05-16160PUT0 0180.53TRUE00
2025-05-16170PUT0 0229.05TRUE00
2025-05-16180PUT0 0223.16TRUE00
2025-05-16190PUT0 0331.1TRUE00
2025-05-16200PUT0 0242.39TRUE00
2025-05-16250PUT0 0472.89TRUE00
2025-06-2010CALL0 00TRUE00
2025-06-2020CALL0 0467.04TRUE00
2025-06-2030CALL0 0214.82TRUE00
2025-06-2040CALL0 0155.55TRUE00
2025-06-2052.5CALL10 093.01TRUE2.50
2025-06-2061.55CALL0 1139.12TRUE00
2025-06-2071.1CALL0 549.88TRUE00
2025-06-2080.65CALL0 10067.41FALSE00
2025-06-2090.6CALL1 11198.82FALSE-0.05-0.08
2025-06-20100.6CALL0 5190.49FALSE00
2025-06-20110CALL0 093.14FALSE00
2025-06-20120CALL0 0101.82FALSE00
2025-06-20130CALL0 0126.4FALSE00
2025-06-20140CALL0 0145.96FALSE00
2025-06-2010PUT0 0454.07FALSE00
2025-06-2020PUT0 0289.71FALSE00
2025-06-2030PUT0 0206.83FALSE00
2025-06-2040PUT0 0121.74FALSE00
2025-06-2050PUT0 0103.22FALSE00
2025-06-2060.71PUT0 1579.71FALSE00
2025-06-2070PUT0 065.41FALSE00
2025-06-2080PUT0 097.84TRUE00
2025-06-2090PUT0 0110.3TRUE00
2025-06-20100PUT0 0111.49TRUE00
2025-06-20110PUT0 0130.32TRUE00
2025-06-20120PUT0 0109.65TRUE00
2025-06-20130PUT0 0156.93TRUE00
2025-06-20140PUT0 0131.28TRUE00
2025-08-1510CALL0 00TRUE00
2025-08-1520CALL0 0307.33TRUE00
2025-08-1533.87CALL0 574.68TRUE00
2025-08-1545.26CALL0 3158.91TRUE00
2025-08-1552.6CALL5 34132.9TRUE2.60
2025-08-1562.42CALL0 23116.24TRUE00
2025-08-1571.7CALL8 795.98TRUE1.70
2025-08-1582CALL0 65463.86FALSE00
2025-08-1591.1CALL0 28777.29FALSE00
2025-08-15100.75CALL0 210105.88FALSE00
2025-08-15110.72CALL0 307125.88FALSE00
2025-08-15120.62CALL5 1564106FALSE0.620
2025-08-15130.41CALL0 60109.55FALSE00
2025-08-15140.55CALL0 39111.34FALSE00
2025-08-15150.47CALL0 1038116.05FALSE00
2025-08-15160.67CALL0 16138.01FALSE00
2025-08-15200.36CALL5 246133.88FALSE0.360
2025-08-15250.1CALL0 94139.91FALSE00
2025-08-1510PUT0 0323.63FALSE00
2025-08-1520.05PUT0 1206.67FALSE00
2025-08-1530.23PUT0 10137.76FALSE00
2025-08-1540.43PUT0 10118.51FALSE00
2025-08-1550.61PUT0 55113.08FALSE00
2025-08-1561.5PUT0 6975.92FALSE00
2025-08-1571.55PUT10 181111.61FALSE1.550
2025-08-1582.35PUT0 1136108.47TRUE00
2025-08-1593.25PUT0 479111.7TRUE00
2025-08-15102.9PUT0 426112.8TRUE00
2025-08-15114.5PUT0 15799.05TRUE00
2025-08-15124.69PUT0 12109.55TRUE00
2025-08-15134.9PUT0 10118.82TRUE00
2025-08-15145.3PUT0 7119.55TRUE00
2025-08-15156PUT0 3122.97TRUE00
2025-08-15166.6PUT0 2999.51TRUE00
2025-08-15200PUT0 0143.14TRUE00
2025-08-15250PUT0 0131.69TRUE00
2025-11-2110CALL0 0281.34TRUE00
2025-11-2120CALL0 0189.28TRUE00
2025-11-2134CALL0 4156.06TRUE00
2025-11-2142.42CALL0 75088.43TRUE00
2025-11-2153.1CALL10 9089.98TRUE0.050.02
2025-11-2162CALL0 191.69TRUE00
2025-11-2171.22CALL0 78397.02TRUE00
2025-11-2181.35CALL0 260.07FALSE00
2025-11-2191.5CALL0 15563.46FALSE00
2025-11-21101.2CALL0 12668.27FALSE00
2025-11-21110.7CALL0 21273.35FALSE00
2025-11-21120CALL0 076.94FALSE00
2025-11-21131.5CALL0 180.68FALSE00
2025-11-21141CALL0 182.12FALSE00
2025-11-21150CALL0 084.16FALSE00
2025-11-21160CALL0 083.87FALSE00
2025-11-21170.35CALL0 2684.45FALSE00
2025-11-2110PUT0 0280.45FALSE00
2025-11-2120PUT0 0175.51FALSE00
2025-11-2130PUT0 0134.92FALSE00
2025-11-2140PUT0 090.28FALSE00
2025-11-2150PUT0 090.98FALSE00
2025-11-2161.95PUT0 2072.55FALSE00
2025-11-2170PUT0 061.55FALSE00
2025-11-2180PUT0 0102.43TRUE00
2025-11-2190PUT0 0103.51TRUE00
2025-11-21100PUT0 077.22TRUE00
2025-11-21114.8PUT0 60101.86TRUE00
2025-11-21120PUT0 086.31TRUE00
2025-11-21130PUT0 073.79TRUE00
2025-11-21140PUT0 088.99TRUE00
2025-11-21150PUT0 0100.38TRUE00
2025-11-21160PUT0 0108.45TRUE00
2025-11-21170PUT0 098.55TRUE00
2025-12-1910CALL0 00TRUE00
2025-12-1920CALL0 0177.25TRUE00
2025-12-1934.26CALL1 1135.13TRUE-0.05-0.01
2025-12-1940CALL0 0122.8TRUE00
2025-12-1950CALL0 085.56TRUE00
2025-12-1963.4CALL0 6594.97TRUE00
2025-12-1972.39CALL1 2996.2TRUE0.110.05
2025-12-1981.79CALL1 3284.72FALSE1.790
2025-12-1992.45CALL0 6561.44FALSE00
2025-12-19101.55CALL0 52066.06FALSE00
2025-12-19112.46CALL0 287.51FALSE00
2025-12-19121.1CALL0 31275.63FALSE00
2025-12-19150.6CALL0 1095.71FALSE00
2025-12-19170.7CALL0 41783.97FALSE00
2025-12-1910PUT0 0263.99FALSE00
2025-12-1920PUT0 0138.74FALSE00
2025-12-1930PUT0 095.9FALSE00
2025-12-1940PUT0 085.13FALSE00
2025-12-1951.1PUT0 2285.85FALSE00
2025-12-1961.96PUT0 668.56FALSE00
2025-12-1972.25PUT0 149101.24FALSE00
2025-12-1980PUT0 0103.54TRUE00
2025-12-1992.75PUT0 79100.09TRUE00
2025-12-19100PUT0 0102.34TRUE00
2025-12-19110PUT0 096.54TRUE00
2025-12-19120PUT0 095.72TRUE00
2025-12-19150PUT0 098.04TRUE00
2025-12-191710.1PUT0 299.84TRUE00
2026-12-1810CALL0 00TRUE00
2026-12-1820CALL0 067.04TRUE00
2026-12-1830CALL0 070.13TRUE00
2026-12-1840CALL0 075.62TRUE00
2026-12-1852.25CALL0 599.92TRUE00
2026-12-1873CALL0 284.64TRUE00
2026-12-18102.42CALL0 778.54FALSE00
2026-12-18122.78CALL0 2059.05FALSE00
2026-12-18151.4CALL1 3876.23FALSE1.40
2026-12-18171.1CALL5 573.62FALSE1.10
2026-12-1810PUT0 0266.74FALSE00
2026-12-1820PUT0 00FALSE00
2026-12-1831.2PUT0 893.19FALSE00
2026-12-1841.8PUT0 1130.41FALSE00
2026-12-1852.17PUT0 2065.02FALSE00
2026-12-1872.17PUT0 3084.96FALSE00
2026-12-18104.7PUT0 1083.49TRUE00
2026-12-18127.1PUT0 167.8TRUE00
2026-12-18159.7PUT0 288.27TRUE00
2026-12-18170PUT0 091.39TRUE00
2027-01-1510CALL0 00TRUE00
2027-01-1520CALL0 064.53TRUE00
2027-01-1530CALL0 0156.16TRUE00
2027-01-1545.4CALL0 191.55TRUE00
2027-01-1553.5CALL1 2763.35TRUE3.50
2027-01-1572.85CALL1 20869.93TRUE2.850
2027-01-15102.2CALL0 1484.79FALSE00
2027-01-15121.9CALL0 687.14FALSE00
2027-01-15151.75CALL0 36692.07FALSE00
2027-01-15171.7CALL0 5466.89FALSE00
2027-01-1510PUT0 00FALSE00
2027-01-1520PUT0 00FALSE00
2027-01-1530PUT0 091.32FALSE00
2027-01-1541.65PUT0 171.08FALSE00
2027-01-1552PUT0 2067.81FALSE00
2027-01-1573.14PUT0 3080.21FALSE00
2027-01-15105.5PUT0 1286.16TRUE00
2027-01-15127.1PUT0 299.19TRUE00
2027-01-15159.5PUT0 196.31TRUE00
2027-01-15170PUT0 096.79TRUE00

Latest OMER Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$2.015
Jun 13, 2022 7:59 PM EST100$2.015
Jun 13, 2022 7:59 PM EST388$2.015
Jun 13, 2022 7:59 PM EST112$2.015
Jun 13, 2022 7:59 PM EST42$2.015

Omeros Corporation (OMER) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020007464/0001558370-20-007464-index.htm
2019-12-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1285819/000000000019016861/0000000000-19-016861-index.htm
2020-01-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1285819/000000000020000924/0000000000-20-000924-index.htm
2018-01-29SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000021545718003528/0000215457-18-003528-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000021545719004932/0000215457-19-004932-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000083423720005992/0000834237-20-005992-index.htm
2017-12-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm
2018-01-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm
2018-01-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318009872/0000899243-18-009872-index.htm
2018-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318009873/0000899243-18-009873-index.htm
2018-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318010008/0000899243-18-010008-index.htm
2018-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017006/0000899243-18-017006-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017007/0000899243-18-017007-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017008/0000899243-18-017008-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017010/0000899243-18-017010-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017011/0000899243-18-017011-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017013/0000899243-18-017013-index.htm
2018-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2019-02-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003362/0000899243-19-003362-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003363/0000899243-19-003363-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003364/0000899243-19-003364-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003365/0000899243-19-003365-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003367/0000899243-19-003367-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016488/0000899243-19-016488-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016489/0000899243-19-016489-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016490/0000899243-19-016490-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016492/0000899243-19-016492-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016495/0000899243-19-016495-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016497/0000899243-19-016497-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016501/0000899243-19-016501-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016504/0000899243-19-016504-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016506/0000899243-19-016506-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319025638/0000899243-19-025638-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319029501/0000899243-19-029501-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319029502/0000899243-19-029502-index.htm
2020-02-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924320004399/0000899243-20-004399-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924320004400/0000899243-20-004400-index.htm
2017-11-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000092963817000842/0000929638-17-000842-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000092963818000300/0000929638-18-000300-index.htm
2020-05-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000092963820000579/0000929638-20-000579-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000104188518000012/0001041885-18-000012-index.htm
2019-01-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000104188519000016/0001041885-19-000016-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000104188520000011/0001041885-20-000011-index.htm
2019-12-04S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1285819/000104746919006632/0001047469-19-006632-index.htm
2019-12-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746919006643/0001047469-19-006643-index.htm
2019-12-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746919006722/0001047469-19-006722-index.htm
2020-08-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004475/0001047469-20-004475-index.htm
2020-08-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004476/0001047469-20-004476-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004572/0001047469-20-004572-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004574/0001047469-20-004574-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000108514620000787/0001085146-20-000787-index.htm
2019-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000110465919070697/0001104659-19-070697-index.htm
2020-01-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1285819/000110465920002951/0001104659-20-002951-index.htm
2020-01-13AWAmendment Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1285819/000110465920003470/0001104659-20-003470-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920021736/0001104659-20-021736-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920021842/0001104659-20-021842-index.htm
2020-08-10FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920092744/0001104659-20-092744-index.htm
2020-08-10305B2Filing [Trust Indenture Act]https://www.sec.gov/Archives/edgar/data/1285819/000110465920092747/0001104659-20-092747-index.htm
2020-08-12FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920093476/0001104659-20-093476-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000110465920095326/0001104659-20-095326-index.htm
2019-03-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000114420419012997/0001144204-19-012997-index.htm
2019-05-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000114420419025259/0001144204-19-025259-index.htm
2017-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312517265505/0001193125-17-265505-index.htm
2017-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312517304636/0001193125-17-304636-index.htm
2017-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312517311379/0001193125-17-311379-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000119312518045759/0001193125-18-045759-index.htm
2018-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518096839/0001193125-18-096839-index.htm
2018-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518116023/0001193125-18-116023-index.htm
2018-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518169610/0001193125-18-169610-index.htm
2018-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518172720/0001193125-18-172720-index.htm
2018-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518195704/0001193125-18-195704-index.htm
2018-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518294184/0001193125-18-294184-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518322542/0001193125-18-322542-index.htm
2018-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518327708/0001193125-18-327708-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312519009075/0001193125-19-009075-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312519036058/0001193125-19-036058-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000119312519038252/0001193125-19-038252-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312519059222/0001193125-19-059222-index.htm
2019-03-01POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1285819/000119312519059276/0001193125-19-059276-index.htm
2019-03-01POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1285819/000119312519059320/0001193125-19-059320-index.htm
2019-06-11S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1285819/000119312519170318/0001193125-19-170318-index.htm
2018-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000003/0001285819-18-000003-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000006/0001285819-18-000006-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000011/0001285819-18-000011-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000014/0001285819-18-000014-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000610/0001415889-20-000610-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000611/0001415889-20-000611-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000612/0001415889-20-000612-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000797/0001415889-20-000797-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001531/0001415889-20-001531-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001532/0001415889-20-001532-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001533/0001415889-20-001533-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001534/0001415889-20-001534-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001535/0001415889-20-001535-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001536/0001415889-20-001536-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001537/0001415889-20-001537-index.htm
2020-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920002497/0001415889-20-002497-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019006625/0001558370-19-006625-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019007697/0001558370-19-007697-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019007698/0001558370-19-007698-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837019007702/0001558370-19-007702-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019010800/0001558370-19-010800-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837019010806/0001558370-19-010806-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020000682/0001558370-20-000682-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020001887/0001558370-20-001887-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1285819/000155837020001891/0001558370-20-001891-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1285819/000155837020004646/0001558370-20-004646-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1285819/000155837020004658/0001558370-20-004658-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020006245/0001558370-20-006245-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837020006254/0001558370-20-006254-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020007464/0001558370-20-007464-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020010177/0001558370-20-010177-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837020010182/0001558370-20-010182-index.htm
2017-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459017023228/0001564590-17-023228-index.htm
2018-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459018004112/0001564590-18-004112-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1285819/000156459018009842/0001564590-18-009842-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459018012972/0001564590-18-012972-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459018021051/0001564590-18-021051-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1285819/000156459019013704/0001564590-19-013704-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459019017957/0001564590-19-017957-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459019022265/0001564590-19-022265-index.htm
2017-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000162828017011326/0001628280-17-011326-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1285819/000162828019002324/0001628280-19-002324-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000162828019006430/0001628280-19-006430-index.htm
2018-10-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999718008375/9999999997-18-008375-index.htm
2019-04-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999719002349/9999999997-19-002349-index.htm
2019-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999719006776/9999999997-19-006776-index.htm
2020-08-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999720004327/9999999997-20-004327-index.htm

Omeros Corporation (OMER) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Omeros Corporation (OMER). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 441%
Institutional Ownership: 5736%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-05-15MICHAEL A JACOBSENVP Finance and CAOBuy5,000.009.3746,850.0013,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselSell62,528.0021.451,341,225.60176,641.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselBuy3,000.006.0518,150.00179,641.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselBuy5,004.006.0530,274.20184,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-07-12Marcia S. KelbonVP Patent and General CounselSell4,277.0021.4891,886.21184,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm
2018-07-26Marcia S. KelbonVP Patent and General CounselSell35,000.0021.53753,686.50184,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2019-12-14Peter A MD DemopulosDirectorBuy3,334.007.5625,205.04188,516.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319029501/0000899243-19-029501-index.htm
2018-07-12Marcia S. KelbonVP Patent and General CounselBuy4,277.004.1017,535.70188,922.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm
2018-07-26Marcia S. KelbonVP Patent and General CounselBuy8,000.006.0548,400.00192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-07-27Marcia S. KelbonVP Patent and General CounselSell5,723.0021.73124,356.78192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-08-30Marcia S. KelbonVP Patent and General CounselSell35,000.0024.45855,750.00192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselSell5,337.0025.93138,376.13192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-05-14MICHAEL A JACOBSENVP Finance and CAOBuy10,980.009.37102,882.6019,480.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselSell2,192.0025.3155,469.44197,982.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-07-27Marcia S. KelbonVP Patent and General CounselBuy5,723.004.1023,464.30198,368.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2017-12-28Gregory A MD DemopulosChairman, CEO & PresidentBuy102,040.002.45249,998.001,987,025.00https://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselBuy7,529.004.1030,868.90200,174.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselBuy8,000.006.0548,400.00200,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2017-12-28Gregory A MD DemopulosChairman, CEO & PresidentBuy39,961.004.10163,840.102,026,986.00https://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm
2019-06-07Marcia S. KelbonVP Patent and General CounselBuy10,000.006.0560,500.00210,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319016488/0000899243-19-016488-index.htm
2018-05-15MICHAEL A JACOBSENVP Finance and CAOBuy12,812.009.37120,048.4421,312.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-07-26Marcia S. KelbonVP Patent and General CounselBuy35,000.004.10143,500.00219,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-08-30Marcia S. KelbonVP Patent and General CounselBuy35,000.004.10143,500.00227,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselBuy62,528.009.37585,887.36239,169.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2019-10-14Thomas J. CableDirectorSell5,000.0015.1275,590.0035,067.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319025638/0000899243-19-025638-index.htm
2019-12-03Thomas J. CableDirectorSell10,000.0014.41144,148.0035,067.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm
2020-05-13Thomas J. CableDirectorSell5,000.0014.4071,998.5035,067.00https://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm
2020-05-13Thomas J. CableDirectorBuy5,000.005.9229,600.0040,067.00https://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm
2019-12-03Thomas J. CableDirectorBuy10,000.007.5675,600.0045,067.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm
2019-12-14Leroy E. MD PhD HoodDirectorBuy10,000.007.5675,600.0064,390.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319029502/0000899243-19-029502-index.htm
2020-03-13Leroy E. MD PhD HoodDirectorBuy5,000.005.9229,600.0069,390.00https://www.sec.gov/Archives/edgar/data/1285819/000141588920000797/0001415889-20-000797-index.htm
2018-01-03MICHAEL A JACOBSENVP Finance and CAOSell1,020.0022.4522,899.007,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm
2018-01-04MICHAEL A JACOBSENVP Finance and CAOBuy1,000.009.379,370.008,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm
2018-05-14MICHAEL A JACOBSENVP Finance and CAOSell10,980.0022.45246,501.008,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-05-15MICHAEL A JACOBSENVP Finance and CAOSell12,812.0024.95319,659.408,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-01-03MICHAEL A JACOBSENVP Finance and CAOBuy1,020.009.379,557.408,520.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm